| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
24,490,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Milestone Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Co.'s product candidate etripamil is a short-acting calcium channel blocker that Co. designed as a rapid-onset nasal spray to be self-administered by patients. Co. is developing etripamil for the treatment of specific arrhythmias with a lead indication to treat paroxysmal supraventricular tachycardia, with subsequent indications to treat atrial fibrillation and rapid ventricular rate and other cardiovascular indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,621,346 |
| Total Buy Value |
$0 |
$0 |
$0 |
$13,891,584 |
| Total People Bought |
0 |
0 |
0 |
6 |
| Total Buy Transactions |
0 |
0 |
0 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
1,557,346 |
| Total Sell Value |
$0 |
$0 |
$0 |
$13,564,484 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wong Roderick |
10% Owner |
– – • |
2019-10-15 |
4 |
B |
$18.00 |
$19,800 |
I/I |
1,100 |
3,535,493 |
1.5 |
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-10-11 |
4 |
B |
$17.30 |
$72,791 |
I/I |
4,208 |
3,534,393 |
1.5 |
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-10-10 |
4 |
B |
$16.00 |
$2,864 |
I/I |
179 |
3,530,185 |
1.42 |
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-10-03 |
4 |
B |
$18.31 |
$34,940 |
I/I |
1,908 |
3,530,006 |
1.5 |
- |
|
| Muller Lorenz |
Chief Commercial Officer |
• – – |
2019-10-01 |
4 |
OE |
$1.54 |
$3,850 |
D/D |
2,500 |
52,115 |
|
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-10-01 |
4 |
B |
$17.63 |
$110,039 |
I/I |
6,242 |
3,528,098 |
1.5 |
- |
|
| Fonds De Solidarite Des Travailleurs Du Quebec |
10% Owner |
– – • |
2019-05-13 |
4 |
B |
$15.00 |
$6,499,995 |
D/D |
433,333 |
2,720,310 |
2.45 |
- |
|
| Fonds De Solidarite Des Travailleurs Du Quebec |
10% Owner |
– – • |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,256,410 |
2,286,977 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2019-05-13 |
4 |
B |
$15.00 |
$4,999,995 |
D/D |
333,333 |
2,674,470 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2019-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,341,137 |
2,341,137 |
|
- |
|
| Douville Philippe |
Chief Scientific Officer |
• – – |
2019-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,124 |
43,392 |
|
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$15.00 |
$10,000,005 |
I/I |
666,667 |
3,521,856 |
1.5 |
- |
|
| Wong Roderick |
10% Owner |
– – • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,855,189 |
2,855,189 |
|
- |
|
| Bdc Capital Inc. |
10% Owner |
– – • |
2019-05-08 |
4 |
B |
$15.00 |
$3,000,000 |
D/D |
200,000 |
2,388,088 |
2.45 |
- |
|
| Oliveto Joseph |
President and CEOOfficer |
• • – |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
273,155 |
|
- |
|
| Douville Philippe |
Chief Scientific OfficerOffice |
• – – |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,268 |
|
- |
|
| Plat Francis |
Chief Medical OfficerOfficer |
• – – |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
11,456 |
|
- |
|
| Muller Lorenz |
Chief Commercial OfficerOffice |
• – – |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
49,615 |
|
- |
|
| Fonds De Solidarite Des Travailleurs Du Quebec |
10% Owner |
– – • |
2019-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,567 |
|
- |
|
44 Records found
|
|
Page 2 of 2 |
|
|
